News
Novus Diagnostics, an innovator in the field of rapid point-of-care diagnostics, announces the appointment of Dr. Margrit ...
Boehringer Ingelheim has slipped another piece of its oncology R&D strategy into place, partnering with Tessellate Bio on a ...
Pharmaceutical Technology on MSN2d
Boehringer to expand oncology presence with $572m Tessellate Bio dealBoehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...
Clarivate Plc , a leading global provider of transformative intelligence, today announced the launch of DRG Commercial Analytics 360?a solution designed to empower medtech companies with advanced ...
Synthetic lethality specialist Tessellate Bio NV has closed its first deal, agreeing to a €500 million-plus (US$570 million) ...
The "Enterprise Tech Ecosystem Series: Boehringer Ingelheim 2025" company profile has been added to ResearchAndMarkets.com's offering. Boehringer Ingelheim International: Leading the Way in ...
Suanfarma, a global company specializing in the development, production, and commercialization of active pharmaceutical ...
Christian Boehringer to hand over as Chairman of the Shareholders’ Committee to Hubertus von Baumbach Shashank Deshpande, Member of the Board of ...
Ingelheim, Germany, and Boston, MA, USA, April 14, 2025 – Boehringer Ingelheim and Cue Biopharma, Inc. (Nasdaq: CUE) today announced a strategic research collaboration and license agreement to develop ...
Ground-breaking drug discovery work at the University of Dundee has been honoured by a major international award.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback